Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bronfeld Zeev
Relationship:   10% Owner
City:   Tel Aviv
State:   L3
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   11,871,004    

Indirect Shares

  42,781,250      
Direct Value   $14,570,718    

Indirect Value

  $1,882,813      
Total Shares   54,652,254      
Total Value   $16,453,531      


Gammacan International Inc
 $0 Oramed Pharmaceuticals Inc
 $13,998,526 Protalix Biotherapeutics
 $572,192 Gammacan International Inc
 $0 Oramed Pharmaceuticals Inc
 $13,998,526 Protalix Biotherapeutics
 $572,192
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Gammacan International Inc GCAN 10% Owner 2004-07-19 3,900,006 0    Premium*  
            Oramed Pharmaceuticals Inc ORMP 10% Owner 2011-09-27 5,808,517 2011-09-27 781,250    Premium*  
            Protalix Biotherapeutics PLX Director 2014-10-02 2,162,481 2014-10-02 0    Premium*  
            Global Energy Inc GEYI 10% Owner 2007-04-30 0 2007-04-30 42,000,000    Premium*  
* Premium Members only  

Records found :    11         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
GEYI Global Energy Inc 10% Owner   –       –       •   2007-04-30 4 B $0.01 $300,000 I/I 30,000,000 42,000,000 1.5 -
PLX Protalix Biotherapeutics Director   –       •       •   2006-12-31 4 A $0.00 $0 I/I 14,466,319 14,466,319 0 -
PLX Protalix Biotherapeutics Director   –       •      –    2014-09-16 4 D $0.00 $0 I/I (8,556,371) 1,509,948 0 -
PLX Protalix Biotherapeutics Director   –       •       •   2014-08-13 4 S $2.47 $10,868,000 I/I (4,400,000) 10,066,319 0 -
PLX Protalix Biotherapeutics Director   –       •      –    2014-09-16 4 A $0.00 $0 D/D 1,838,109 1,838,109 0 -
PLX Protalix Biotherapeutics Director   –       •      –    2014-10-02 4 D $0.00 $0 I/I (1,509,948) 0 0 -
ORMP Oramed Pharmaceuticals In... 10% Owner   –       –       •   2011-03-31 4 B $0.32 $250,000 I/I 781,250 7,213,205 1.5 -
ORMP Oramed Pharmaceuticals In... 10% Owner   –       –       •   2011-09-27 4 S $0.28 $98,000 D/D (350,000) 5,808,517 0 -
PLX Protalix Biotherapeutics Director   –       •      –    2014-10-02 4 A $0.00 $0 D/D 324,372 2,162,481 0 -
GCAN Gammacan International In... 10% Owner   –       –       •   2004-07-19 3 IO $0.00 $0 D/D 0 3,900,006 -
ORMP Oramed Pharmaceuticals In... 10% Owner   –       –       •   2006-02-03 3 IO $0.00 $0 D/D 0 6,158,517 -

  11  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed